LIXTE Biotechnology plans to invest 25% of its treasury in Bitcoin and other cryptocurrencies

According to news from Hash Chain, the board of LIXTE Biotechnology Holdings has approved a strategic capital allocation plan to invest up to 25% of corporate funds in the cryptocurrency sector, including Bitcoin and other digital assets. The specific transaction models and timing will be determined based on market conditions and strategic considerations.